April 7 (Reuters) - Supernus Pharmaceuticals Inc SUPN.O:
SUPERNUS PHARMACEUTICALS INC - ENTERS ASSET PURCHASE AGREEMENT WITH NAVITOR ON APRIL 1, 2026 - SEC FILING
SUPERNUS PHARMACEUTICALS INC - TO BUY ASSETS RELATED TO NV-5138 OR SPN-820 INCLUDING IP AND INVENTORY - SEC FILING
SUPERNUS PHARMACEUTICALS INC - PURCHASE PRICE INCLUDES PHASE 2B STUDY AND MILESTONE PAYMENTS UP TO $350 MILLION - SEC FILING
SUPERNUS PHARMACEUTICALS INC - AGREEMENT INCLUDES FIVE-YEAR NON-COMPETE AND NON-SOLICITATION COVENANT - SEC FILING
Source text: [ID:n0001104659-26-040497]